These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7990105)

  • 41. Postjunctional regulation by angiotensin II of alpha 1-adrenoceptor-mediated pressor responses in the rat.
    Marano G; Argiolas L
    Eur J Pharmacol; 1994 Aug; 261(1-2):121-6. PubMed ID: 8001634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
    Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
    Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and Antihypertensive Action of New Imidazo[1,2-a]pyridine Derivatives , non Peptidic Angiotensin II Receptor Antagonists.
    Laneri S; Di Ronza C; Bernardi A; Ostacolo C; Sacchi A; Cervone C; D'Amico M; Di Filippo C; Letizia Trincavelli M; Panighini A; Martini C
    Cardiovasc Hematol Disord Drug Targets; 2011; 11(2):87-96. PubMed ID: 26302898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis.
    Madrid MI; García-Salom M; Tornel J; De Gasparo M; Fenoy FJ
    Am J Physiol; 1997 Nov; 273(5):R1676-82. PubMed ID: 9374809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.
    Duncia JV; Chiu AT; Carini DJ; Gregory GB; Johnson AL; Price WA; Wells GJ; Wong PC; Calabrese JC; Timmermans PB
    J Med Chem; 1990 May; 33(5):1312-29. PubMed ID: 2329553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
    Keiser JA; Ryan MJ; Panek RL; Hodges JC; Sircar I
    J Pharmacol Exp Ther; 1995 Mar; 272(3):963-9. PubMed ID: 7891350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on nonpeptide angiotensin II receptor antagonists. III. Synthesis and biological evaluation of 5-alkylidene-3,5-dihydro-4H-imidazol-4-one derivatives.
    Okazaki T; Kikuchi K; Watanabe T; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 May; 46(5):777-81. PubMed ID: 9621411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of angiotensin II AT1- or AT2-receptor antagonists on drinking evoked by angiotensin II or water deprivation in rats.
    Widdop RE; Gardiner SM; Bennett T
    Brain Res; 1994 Jun; 648(1):46-52. PubMed ID: 7922526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.
    Carini DJ; Duncia JV; Aldrich PE; Chiu AT; Johnson AL; Pierce ME; Price WA; Santella JB; Wells GJ; Wexler RR
    J Med Chem; 1991 Aug; 34(8):2525-47. PubMed ID: 1875348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview.
    Brunner HR
    J Hum Hypertens; 2002 May; 16 Suppl 2():S13-6. PubMed ID: 11967728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of angiotensin II chronotropic effect in anaesthetized dogs.
    Lambert C
    Br J Pharmacol; 1995 Jul; 115(5):795-800. PubMed ID: 8548179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives.
    Okazaki T; Watanabe T; Kikuchi K; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):973-81. PubMed ID: 9658576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist.
    Olins GM; Corpus VM; Chen ST; McMahon EG; Palomo MA; McGraw DE; Smits GJ; Null CL; Brown MA; Bittner SE
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):617-25. PubMed ID: 7505365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptor subtypes mediating spinal cardiovascular effects of angiotensin II in rat using losartan and PD 123319.
    Park PD; Henry JL
    Eur J Pharmacol; 1997 May; 326(2-3):139-45. PubMed ID: 9196266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Imai K; Inamura N; Asano M; Hatori C; Katayama A; Oku T; Tanaka H
    J Med Chem; 1998 Feb; 41(4):564-78. PubMed ID: 9484506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of luminal angiotensin II receptor antagonists on proximal tubule transport.
    Quan A; Baum M
    Am J Hypertens; 1999 May; 12(5):499-503. PubMed ID: 10342788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.
    Bernhart CA; Perreaut PM; Ferrari BP; Muneaux YA; Assens JL; Clément J; Haudricourt F; Muneaux CF; Taillades JE; Vignal MA
    J Med Chem; 1993 Oct; 36(22):3371-80. PubMed ID: 8230127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts.
    Ford WR; Clanachan AS; Jugdutt BI
    Circulation; 1996 Dec; 94(12):3087-9. PubMed ID: 8989113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
    Coca A; Giner V
    Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.